Altido Bio has closed a $12.5 million seed round led by ARCH Venture to commercialize CAR-T therapy for glioblastoma tumors, promoting cancer treatment advancement.
Amount Raised
$12.5 Million
Round Type
Seed
Investors
Description
Altido Bio has successfully raised $12.5 million in a seed funding round to develop CAR-T cell therapy for glioblastoma. Led by ARCH Venture, the funding will aid in advancing experimental treatments for this deadly brain tumor. Initial data shows promise, with one patient remaining healthy over 2.5 years post-treatment.
Quick answer
Altido Bio raised $12.5 Million in a Seed round, dated January 28, 2026. Investors: ARCH Venture.
- How much did Altido Bio raise?
- Altido Bio raised $12.5 Million in a Seed round on January 28, 2026.
- Who invested in Altido Bio?
- ARCH Venture is named as investors in this round.
- What does Altido Bio do?
- Altido Bio is a startup focused on developing CAR-T cell therapy for glioblastoma tumors.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Altido Bio that raised within 45 days of this round, from Fundz verified event records.
- Combat Medical raised $3.5M (Series A) on March 12, 2026.
- GenSight Biologics raised $2M (Post-IPO Equity) on March 10, 2026.
- Prolium Bioscience raised $50M (Series A) on March 5, 2026.
- NexCure raised $19M (Series A) on March 5, 2026.
- Os Therapies raised $2M on March 4, 2026.
- Polares Medical SA raised $50M (Series C) on March 3, 2026.
Who to call at Altido Bio, and when
A new round usually means Altido Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Altido Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Altido Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Altido Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Altido Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Altido Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.